Our study focused on the mechanism of resistance acquisition to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancers (NSCLCs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.